Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy
Leuk Lymphoma
.
2023 Mar;64(3):750-752.
doi: 10.1080/10428194.2023.2172981.
Epub 2023 Feb 1.
Authors
Konstantinos Lontos
1
2
,
Anastasia Tsagianni
1
,
Mounzer Agha
1
,
Anastasios Raptis
1
,
Jing-Zhou Hou
1
,
Rafic Farah
1
,
Robert L Redner
1
,
Annie Im
1
,
Kathleen A Dorritie
1
,
Alison Sehgal
1
,
James Rossetti
1
,
Nidhi Aggarwal
3
,
Melissa Saul
4
,
Michael Boyiadzis
1
,
Nathanael G Bailey
3
Affiliations
1
UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
2
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
3
Department of Pathology, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.
4
Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
PMID:
36722791
PMCID:
PMC10257893
DOI:
10.1080/10428194.2023.2172981
No abstract available
Publication types
Research Support, N.I.H., Extramural
MeSH terms
Biopsy
Bone Marrow Cells* / pathology
Bone Marrow* / pathology
Humans
Prognosis
Remission Induction
Grants and funding
TL1 TR001858/TR/NCATS NIH HHS/United States